UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Transmyocardial laser revascularisation. Experimental and clinical studies

Huikeshoven, M.

Link to publication

Citation for published version (APA):Huikeshoven, M. (2002). Transmyocardial laser revascularisation. Experimental and clinical studies

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 01 Sep 2018

References

1. Heberden W. Some account of a disorder of the breast. Med Trans R Coll Physicians (Lond) 1772:2:59-67

2. Gibbons RJ. Chatterjee K. Daley J. Douglas JS, Finn SD. Gardin JM, Grunwald MA, et al.. ACC/AHA/ACP-AS1M guidelines for the management of patients with chronic stable angina. Circulation 1999;99:2829-48

3. Crea F, Pupita G, Galassi A, El-Tamimi H, Kaski JC, Davies G, Mascri A. Role of adenosine in pathogenesis of angina pain. Circulation 1990;81:164-72

4. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience 1992;48:501-42

5. Kennard MA, Haugen FP. The relation of subcutaneous focal sensitivity to referred pain of cardiac origin. Anesthesiology- 1955; 16:297

6. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Boston, Mass: Little, Brown & Co, 1994

7. Braunwald E. Unstable angina: A classification. Circulation 1989;80:410-4 8. Frishman WH. Beta adrenergic blockers. Med Clin North Am 1988:72:37-81 9. Thadani U. Selective L-typc, T-typc, and non-specific calcium-channel blockers for stable angina

pectoris. Am Heart J 2002;144:8-10 10. Abrams J. Therapy of angina pectoris with long acting nitrates: Which agent and when? Can J Cardiol

1996;12(SupplC):9C-16C 11. Patrono C. Aspirin as an antiplatelet drug. New Engl J Med 1994:330:1287-94 12. Beck CS. The development of a new blood supply to the heart by operation. Ann Surg 1935;102:801-13 13. Vineberg A. Clinical and experimental studies in the treatment of coronary artery insufficiency by

internal mammary artery implant. J Inter Coll Surg 1954;22:503-18 14. Vineberg A. Evidence that revascularization by ventricular-internal mammary artery implants increases

longevity. Twenty-four year, nine month follow-up. J Thorac Cardiovasc Surg 1975;70:381-97 15. Waern J, Mettier S, Klumpp T. Zschicsche L. The nature of the vascular communications between the

coronary arteries and the chambers of the heart. Am Heart J 1933;9:143-64 16. Sen P, Udwadia T, Kinare S. Parulkar G. Transmyocardial revascularization: A new approach to

myocardial revascularization. J Thorac Cardiovasc Surg 1965;50:181-9 17. Kohmoto T, Argenziano M, Yamamoto N, Vliet KA, Gu A, Derosa CM, Fisher PE, et al.. Assessment

of transmyocardial perfusion in alligator hearts. Circulation 1997;95:1585-91 18. O'Connor WN, Cash JB, Cottrill CM, Johnson GL, Noonan JA. Ventriculocoronary connections in

hypoplastic left hearts: An autopsy microscopic study. Circulation 1982;66:1078-86 19. Bonnet D, Gautier-Lhermittc I. Bonhoeffer P. Sidi D. Right ventricular myocardial sinusoidal-coronary

artery connections in critical pulmonary valve stenosis. Ped Cardiol 1998;19:269-71 20. Goldman A, Greenstone SM, Preuss FS, Strauss SH, Chang ES. Experimental methods for producing a

collateral circulation to the heart directly from the left ventricle. J Thorac Surg 1956;31:364-74 21. Massimo C, Boffi L. Myocardial revascularization by a new method of carrying blood directly from

the left ventricular cavity into the coronary circulation. J Thorac Surg 1957;34:257-64 22. Hershey JE, White M. Transmyocardial puncture revascularization. A possible emergency adujet to

arterial implant surgery. Geriatrics 1969;24:101-8 23. Pifarre R, Jasuja M, Lynch R, Neville W. Myocardial revascularization by transmyocardial

acupuncture: A physiologic impossibility. J Thorac Cardiovasc Surg 1969;58:424-31 24. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction: Description of a new

technique and preliminary report of its application. Circulation 1964;3:654-70 25. Griintzig A, Hopff H. Perkutanc rckanalisation chronischer artericllcr vcrschliisse mit einem neucn

dilatationskatheter. Dtsch Med Wochenschr 1974;99:2502-5 26. Serruys PW, Luijten HE, Beatt KJ, Geuskcns R. de Feyter PJ, van den Brand M, Reiber JH, et al..

Incidence of restenosis after succesful coronary angioplasty: A time-related phenomenon. Circulation 1988:77:361-71

27. Dotter CT, Buschmann PAC, McKinney MK, Rösch J. Transluminal expandable nitinol coil stent grafting: Preliminary report. Radiology 1983:147:259-60

References 28. Grunzig AR. King SB. Schlumpf M, Siegenthaler W. Long-term follow-up after percutaneous

transluminal coronary angioplasty: The early Zurich experience. New Engl J Med 1987;316:1127-32 29. Favalaro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion:

Operative technique. Ann Thorac Surg 1968:5:334-9 30. Bourassa MG. Long-term vein graft patency. Cnrr Opin Cardiol 1994:9:685-91 31. Cameron AAC. Davis KB, Rogers WJ. Recurrence of angina after coronary bypass surgery. Predictors

and prognosis (CASS registry). J Am Coll Cardiol 1995;26:895-9 32. Mannheimer C. Camici P. Chester MR. Collins A. DeJongste M. Eliasson T, Follath F. et al.. The

problem of refractory angina. Eur Heart J 2002;23:355-70 33. Takeshita S. Zheng LP, Brogi E. Therapeutic angiogenesis: A single intra-arterial bolus of vascular

endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J Clin Invest 1994;93:662-70

34. van Royen N, Piek JJ. Buschmann I, Hoefer I, Voskuil M, Schaper W. Stimulation of arteriogencsis; A new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001;49:543-53

35. Mannheimer C. Carlsson CA, Vedin A. Wilhelmsson C. Transcutaneous electrical nerve stimulation (TENS) in angina pectoris. Pain 1986:26:291-300

36. Melzack R, Wall PD. Pain mechanisms: A new theory. Science 1965;150:971-9 37. Eliasson T. Augustinsson L-E. Mannheimer C. Spinal cord stimulation in severe angina pectoris -

presentation of current studies, indications and clinical experience. Pain 1996;65:169-79 38. Mannheimer C, Eliasson T, Augustinsson L-E. Blomstrand C. Emanuelsson H, Larsson S, Norrsell H.

et al.. Electrical stimulation versus coronary artery bypass surgery in severe angina pectoris: The ESBY study. Circulation 1998;97:1157-63

39. Blomberg S. Curelaru I. Emanuelsson H. I lerlitz J. Ponten J. Ricksten SE. Thoracic epidural anesthesia in patients with unstable angina pectoris. Eur Heart J 1989:10:437-44

40. Gramling-Babb P. Miller M. Reeves S. Roy R. Zile M. Treatment of medically and surgically refractory angina pectoris with high thoracic epidural analgesia: Initial clinical experience. Am Heart J 1997;133:648-55

41 . Wiener L. Cox W. Influence of stellate ganglion block on angina pectoris and the post-exercise electrocardiogram. Am J MedSci 1966;252:289-95

42. I Iammond C. Leach A. Chester M. Temporary sympathectomy for refractory angina. Brit Med J 1999:81 (Suppl I): 19

43. Wetterwik C, Claes G. Drott C. Endoscopic transthoracic sympathicotomy for severe angina. Lancet 1995;345:97-8

44. Urano H. Ikeda J, Ueno T. Matsumoto T. Murohara T. Imaizumi T. Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 2001;37:93-9

45. Leschke M, Schoebel F-C. Mecklenbeck W, Stein D. .lax TW, Miiller-Gartner H-W, Strauer B-E. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: A randomized dose-response trial. J Am Coll Cardiol 1996;27:575-84

46. Mirhoseini M. Cayton MM. Revascularization of the heart by laser. J Microsurg 1981 ;2:253-60 47. Mirhoseini M. Fisher JC. Cayton M. Myocardial revascularization by laser: A clinical report. Lasers

Surg Med 1983;3:241-5 48. van der Wouw PA, van der Sloot JAP, van der Meulen J, Tukkie R, Beek JF. Transmyocardial laser

channels. J Am Soc Echocardiog 1998:11:986-8 49. Whittakcr P. Rakusan K, Kloner RA. Transmural channels can protect ischemic tissue. Assessment of

long-term myocardial response to laser-and needle-made channels. Circulation 1996:93:143-52 50. Malekan R. Reynolds C, Narula N. Kellcy ST. Suzuki Y, Bridges CR. Angiogenesis in

transmyocardial laser revascularization -a nonspecific response to injury. Circulation 1998;98:1162-5 51. Komowski R. Epstein SE, Leon MB, eds. Handbook of myocardial revascularization and angiogenesis.

London: Martin Dunitz Ltd, 2000 52. Shawl FA, Kaul U. Saadat V. Percutaneous myocardial revascularization using a myocardial channeling

device: First human experience using the AngioTrax system. J Am Coll Cardiol 2000;35:61 A 53. Smith NB, Hynynen K. The feasibility of using focused ultrasound for transmyocardial

revascularization. Ultrasound Med Biol 1998;24:1045-54

136

54. Khairy P. Dubuc M. Gallo R. Cryoapplication induces neovascularization: A novel approach to percutaneous myocardial revascularization. J Am Coll Cardiol 20Q0;35:5A-6A

55. Dietz U, Darius H, Eick O, Buerke M, El Odeh R. Transmyocardial revascularisation using temperature controlled HF energy creates reproducible intramyocardial channels. Circulation 1998:98:3770

56. Yamamoto N, Gu AG, Derosa CM, Shimizu J, Zwas DR, Smith CR, Burkhoff D. Radio frequency transmyocardial revascularization enhances angiogenesis and causes myocardial denervation in a canine model. Lasers Surg Med 2000;27:18-28

57. Spaulding CM, Souza LCG, Richard P, Pouzet B, Bowden R, Faas B, Tissier F, et al.. Percutaneous myocardial revascularization with a newly developed high pressure saline-jet system: Evaluation of acute and chronic effects in porcine hearts. J Am Coll Cardiol 2001;37:48A

58. Oesterle SN, Sanborn TA, Ali N, Resar J, Ramee SR, Heuser R, Dean L, et al.. Percutaneous transmyocardial laser revascularisation for severe angina: The PACIFIC randomised trial. Lancet 2000;356:1705-10

59. Allen KB, Dowling RD, DelRossi AJ, Realyvasques F, Lefrak EA, Pfeffer TA, Fudge TL, et al.. Transmyocardial laser revascularization combined with coronary artery bypass grafting: A multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 2000; 119:540-7

60. Fleischer KJ, Goldschmidt-Clermont PJ, Fonger JD, Hutchins GM, Hruban RH, Baumgartner WA. One-month histologic response of transmyocardial laser channels with molecular intervention. Ann Thorac Surg 1996;62:1051-8

61. Sayeed-Shah U, Mann MJ, Martin J, Grachev S, Reimold S, Laurence R, Dzau V, et al.. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. J Thorac Cardiovasc Surg 1998; 116:763-8

62. Doukas J, Ma CL, Craig D, Caliste XA, Suehiro K, Zhu SM, Pierce GF, et al.. Therapeutic angiogenesis induced by FGF-2 gene delivery combined with laser transmyocardial revascularization. Circulation 2000:102:1214

63. Lutter G, Dern P, Attmann T, Handkc M, Ameer K, Schreiber J, Buerkle M, et al.. Combined use of transmyocardial laser revascularisation with basic fibroblastic growth factor in chronically ischemic porcine hearts. Circulation 2000; 102:3693

64. Yamamoto N, Kohmoto T, Roethy W, Gu A, DeRosa C, Rabbani LE, Smith CR, et al.. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Res Cardiol 2000;95:55-63

65. Guo JX, Pan J, Ma L, Chen MZ, Xu H, Shi AY. Experimental studies of laser myocardial revascularization in rats. Chin Med J 1993;106:665-7

66. Whittakcr P, Spariosu K, Ho ZZ. Success of transmyocardial laser revascularization is determined by the amount and organization of scar tissue produced in response to initial injury: Results of ultraviolet laser treatment. Lasers Surg Med 1999;24:253-60

67. Jecvanandam V, Auteri JS, Oz MC, Watkins J, Rose EA, Smith CR. Myocardial revascularization by laser-induced channels. Surg Forum 1990:41:225-7

68. Theisen D. Brinkmann R, Stubbe H, Birngruber R. Myocardial tissue ablation by single high-energy laser pulses for ELR and TMR. SPIE 1998;3564:60-7'

69. Genyk IA, Frenz M, Ott B, Walpoth BH, Schaffner T, Carrel TP. Acute and chronic effects of transmyocardial laser revascularization in the nonischemic pig myocardium by usina three laser systems. Lasers Surg Med2000;27:438-50

70. Welch AJ, van Gemert MJC, eds. Optical-thermal response of laser-irradiated tissue. New York: Plenum Press, 1995

71. Sachinopoulou A, Verdaasdonk RM, Beek JF. Comparison of ablation channels created by the ultrapulse C02 laser, the Holmium laser and the 308 nm excimer laser in view of transmyocardial revascularization. SPIE 1996;2671:42-8

72. Oraevsky AA, Jacques SL. Pettit GH. Saisi IS. Tittel FK. Henry PD. XeCl laser ablation of atherosclerotic aorta; Optical properties and energy pathways. Lasers Surg Med 1992;12:585-97

73. Linsker R, Srinivasan R, Wynne JJ, Alonso DR. Far-ultraviolet ablation of atherosclerotic lesions. Lasers Surg Med 1984;4:201-6

74. Cross FW, Bowker TJ. The physical properties of tissue ablation with excimer lasers. Med lustrum 1987;21:226-30

137

References 75. Brugmans MJP. Kemper J. Gijsbers GHM, van der Meulen FW. van Gcmert MJC. Temperature

response of biological materials to pulsed non-ablative COs laser irradiation. Lasers Surg Med 1991;11:587-94

76. Meijering LJ. van Gemert MJC. Gijsbers GHM, Welch AJ. Limits of radial time constants to approximate thermal response of tissue. Lasers Surg Med 1993:13:685-7

77. Khazei A. Kime W, Papadopoulos C, Cowley R. Myocardial canalization: A new method of myocardial revascularization. Ann Thorac Surg 1968;6:163-71

78. White M. Hersey J. Multiple transmyocardial puncture revascularization in refractory ventricular fibrillation due to myocardial ischemia. Ann Thorac Surg 1968:6:557-63

79. Kuzela L. Miller GE. Experimental evaluation of direct transventricular revascularization. J Thorac Cardiovasc Surg 1969:57:770-3

80. Hardy RI, Bove KE, James FW, Kaplan S, Goldman L. A histologic study of laser-induced transmyocardial channels. Lasers Surg Med 1987:6:563-73

81. Okada M, Ikuta H. Shimizu OK, Horii H, Nakamura K. Alternative method of myocardial revascularization by laser: Experimental and clinical study. Kobe J Med Sci 1986:32:151-61

82. Kadipasaoglu KA, Pehlivanoglu S, Conger JL. Sasaki E. de Villalobos DH, Cloy M, Piluiko V. et al.. Long- and short-term effects of transmyocardial laser revascularization in acute myocardial ischemia. Lasers Surg Med 1997:20:6-14

83. Horvath KA, Smith WJ, Laurence RG, Schoen FJ. Appleyard RF, Colin LH. Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol 1995;25:258-63

84. Mack CA. Magovem CJ. Hahn RT, Sanborn T. Lanning L. Ko W, Isom OW, et al.. Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: Results and comparisons to nonlased channels. Circulation 1997;96:1165-9

85. Ozaki S. Meyns B, Racz R, Verbeken E, Leunens V. Dohmen P. Flameng W. Effect of transmyocardial laser revascularisation on chronic ischaemic hearts in sheep. Eur J Cardiothorac Surg 2000; 18:404-10

86. Lutter G. Martin J, Riede UN. Esenwein P, Bitu-Moreno J. Beyersdorf F. Pathomorphological and histological analysis of the indirect revascularization method. Thorac Cardiovasc Surg 2000;48:255-62

87. Whittaker P. Abcla GS. eds. Direct myocardial revascularization: History, methodology, technology. Boston: Kluwer Academic Publishers, 1999

88. Kohmoto T. Fisher PE. Gu A, Zhu SM. Yano OJ, Spotnitz HM. Smith CR. et al.. Does blood flow through holmium:YAG transmyocardial laser channels? Ann Thorac Surg 1996:61:861-8

89. Fisher PE. Khomoto T, Derosa CM. Spotnitz HM, Smith CR, Burkhoff D. Histologic analysis of transmyocardial channels: Comparison of C 0 2 and hohnium:YAG lasers. Ann Thorac Surg 1997;64:466-72

90. Kohmoto T. Fisher PE, Gu A. Zhu SM. Derosa CM. Smith CR. Burkhoff D. Physiology', histology, and 2-week morphology of acute transmyocardial channels made with a CGs laser. Ann Thorac Surg 1997;63:1275-83

91. Kohmoto T, Derosa CM, Yamamoto N, Fisher PE, Failey P, Smith CR. Burkhoff D. Evidence of vascular growth associated with laser treatment of normal canine myocardium. Ann Thorac Surg 1998;65:1360-7

92. Yamamoto N. Kohmoto T. Gu AG. DeRosa C. Smith CR. Burkhoff D. Angiogencsis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 1998;31:1426-33

93. Lu CH, Yu TJ, Lai ST. Transmyocardial holmium-YAG laser channels in an animal model: A preliminary morphologic and histologic study. Chin Med J 1999:62:614-8

94. Goda T, Wierzbicki Z. Gaston A. Leandri J. Vouron J. Loisancc D. Myocardial revascularisation by C 0 2 laser. Eur Surg Res 1987:19:113-7

95. Mueller XM, Tcvaearai HH. Genton CY. Bettex D. von Segesscr LK. Transmyocardial laser revascularisation in acutely ischaemic myocardium. Eur J Cardiothorac Surg 1998;13:170-5

96. Chu VF, Giaid A, Kuang JQ, McGinn AN, Li CM, Pelletier MP, Chiu RCJ. Angiogenesis in transmyocardial revascularization: Comparison of laser versus mechanical punctures. Ann Thorac Surg 1999;68:301-8

97. Mueller XM. Tevaearai HT. Genton CY. von Segesscr LK. Myocardial scarring after transmyocardial laser revascularization: A potential mechanism of clinical improvement? Lasers Surg Med 1999;25:79-87

138

98. Malekan R, Kelley ST, Suzuki Y, Reynolds C, Plappcrt T, Sutton MSJ, Edmunds LH, et al.. Transmyocardial laser revascularization fails to prevent left ventricular functional deterioration and aneurysm formation after acute myocardial infarction in sheep. J Thome Cafdiovasc Surg 1998;116:752-61

99. Eckstein FS, Scheule AM, Vogel L', Schmid ST, Miller S, Jurmann MJ, Zicmer G, et al.. Transmyocardial laser revascularisation in the acute ischaemic heart: No improvement of acute myocardial perfusion or prevention of myocardial infarction. Eur J Cardiothorac Surg 1999;15:702-8

100. Owen ER, Canfield P, Bryant K, Hopwood PR. Observations on the effects of C02-laser on rat myocardium. Microsurgery 1984;5:140-3

101. Burkhoff D, Fisher PE, Apfelbaum M, Kohmoto T, Derosa CM, Smith CR. Histologic appearance of transmyocardial laser channels after 4 1/2 weeks. Ann Thorac Surg 1996;61:1532-4

102. Gassier N. Wintzer HO, Stubbe HM, Wullbrand A, Helmchen U. Transmyocardial laser revascularization. Histological features in human nonrcsponder myocardium. Circulation 1997;95:371-5

103. Domkowski PW, Biswas SS. Steenbergen C, Lowe JE. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation 2001;103:469-71

104. van der Sloot JAP. Huikeshoven M, van der Wal AC, Tukkie R, van Gemert MJC, Beek JF. Angiogenesis three months after clinical transmyocardial laser revascularization using an excimer laser. Lasers Surg Med 2001 ;29:369-73

105. Whittaker P. Transmyocardial revascularization: The fate of myocardial channels. Ann Thorac Surg 1999;68:2376-82

106. Brilla CG, Rybinski L, Gehrke D, Rupp H. Transmyocardial laser revascularization: A novel pathophysiological concept. Tlerz 1997;22:183-9

107. Kohmoto T, Fisher PE, DeRosa C, Smith CR, Burkhoff D. Evidence of angiogenesis in regions treated with transmyocardial laser revascularization. Circulation 1996:94:1294

108. Zlotnick AY, Ahmad RM, Reul RM. Neovascularization occurs at the site of closed laser channels after transmyocardial laser revascularization. Surg Forum 1996;48:286-7

109. Spanier T, Smith CR, Burkhoff D. Angiogenesis: A possible mechanism underlying the clinical benefits of transmyocardial laser revascularization. J Clin Laser Med Surg 1997;15:269-73

110. Chiotti K, Choo SJ, Martin SL, Reichcrt C, Grass TM, Duran CMG. Activation of myocardial angiogenesis and upregulation of Fibroblast growth factor-2 in transmyocardial-revascularization-treated mice. Coronary Artery Dis 2000; 11:537-44

111. Hughes GC, Kypson AP, Annex BH, Yin BL, Louis JDS, Biswas SS, DeGrado TR, et al.. Induction of angiogenesis after TMR: A comparison of holmium:YAG, CO^, and excimer lasers. Ann Thorac Surg 2000;70:504-9

112. Mueller XM. Tevaearai HT, Chaubert P, Gcnton CY, von Segesscr LK. Does laser injury induce a different neovascularisation pattern from mechanical or ischaemic injuries? Heart 2001 ;85:697-701

113. Hughes GC, Lowe JE, Kypson AP, St.Louis JD, Pippen AM, Peters KG, Coleman RE, et al.. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg 1998;66:2029-36

114. Pelletier MP, Giaid A, Sivaraman S, Dorfman J, Li CM, Philip A, Chiu RCJ. Angiogenesis and growth factor expression in a model of transmyocardial revascularization. Ann Thorac Surg 1998;66:12-8

115. Chu V, Kuang J, McGinn A, Giaid A, Korkola S, Chiu RC. Angiogenic response induced by mechanical transmyocardial revascularization. J Thorac Cardiovasc Surg 1999; 118:849-56

116. Horvath KA, Chiu E, Maun DC, Lomasney JW, Greene R, Pearce WH, Fullerton DA. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 1999;68:825-9

117. Li W, Chiba Y, Kimura T, Morioka K, Uesaka T, lhaya A, Muraoka R. Transmyocardial laser revascularisation induced angiogenesis correlated with the expression of matrix metalloproteinases and platelet-derived endothelial cell growth factor. Eur J Cardiothorac Surg 2001; 19:156-63

118. Mueller XM, Tevaearai HT, Genton CY, Chaubert P, von Segesscr LK. Are there vascular density gradients along myocardial laser channels? Ann Thorac Surg 1999;68:125-9

119. Mueller XM, Tevaearai HT, Genton CY, Chaubert P, von Segesscr LK. Improved neoangiogenesis in transmyocardial laser revascularization combined with angiogenic adjunct in a pig model. Clin Sci 2000:99:535-40

139

References 120. Whittaker P. Kloncr RA. Transmural channels as a source of blood flow to ischemic myocardium?

Insights from the reptilian heart. Circulation 1997:95:1357-9 121. Hughes GC, Kypson AP, St Louis JD, Annex BH. Coleman RE. DeGrado TR, Donovan CL. et al..

Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. Ann Thorac Surg 1999:67:1714-20

122. Martin JS. Sayeed-Shah U, Byrne JG. Danton MHD, Flores KQ. Laurence RG. Cohn LH. Excimer versus carbon dioxide transmyocardial laser revascularization: Effects on regional left ventricular function and perfusion. Ann Thorac Surg 2000:69:1811-6

123. Hardy RI, James FW, Millard RW, Kaplan S. Regional myocardial blood flow and cardiac mechanics in dog hearts with C O : laser-induced intramyocardial revascularisation. Basic Res Cardiol 1990;85:179-97

124. Landrcneau R. Nawarawong W. Laughlin H. Ripperger J, Brown O. McKown D. Curtis J. Direct CGs laser "revascularization" of the myocardium. Lasers Surg Med 1991; 11:35-42

125. Lutter G. Yoshitake M. Takahashi N, Nitzsche E, Martin J, Sarai K. Lutz C. et al.. Transmyocardial laser - revascularization: Experimental studies on prolonged acute regional ischemia. Eur J Cardiothorac Surg 1998; 13:694-701

126. Lutter G, Martin J. Takahashi N, Yoshitake M, Schwarzkopf J. Nitzsche E, Beyersdorf F. Transmyocardial laser revascularization: Experimental studies in healthy porcine myocardium. Ann Thorac Surg 1999:67:1708-13

127. Lutter G. Martin J, von Samson P, Heilmann C. Sarai K, Beyersdorf F. Micropcrfusion enhancement after TMLR in chronically ischemic porcine hearts. Cardiovasc Surg 2001;9:281-91

128. Whittaker P. Kloncr RA, Przyklenk K. Laser-mediated transmural myocardial channels do not salvage acutely ischemic myocardium. J Am Coll Cardiol 1993;22:302-9

129. Kohmoto T, Uzun G, Gu A, Zhu SM, Smith CR. Burkhoff D. Blood flow capacity via direct acute myocardial revascularization. Basic Res Cardiol 1997:92:45-51

130. Hamawy AH. Lee LY. Samy SA, Poke DR. Szulc M. Vazquez M. Rosengart TK. Transmyocardial laser revascularization dose response: Enhanced perfusion in a porcine ischemia model as a function of channel density. Ann Thorac Surg 2001;72:817-22

131. Burkhoff D. Jones JW, Becker LC. Large variability in results may limit utility of thallium scans to detect improved blood flow in response to TMR or angiogenic therapies. Circulation 2000; 102:3139

132. Sylven C. Neurophysiological aspects of angina pectoris. Z Kardiol 1997;86:95-105 133. Barber MJ, Mueller TM, Davies BG. Zipes DP. Phenol topically applied to canine left ventricular

epicardium interrupts sympathetic but not vagal afferents. Circ Res 1984;55:532-44 134. Stevens MJ. Raffel DM. Allman KC, Dayanikli F. Ficaro E, Sandford T. Wieland DM. et al.. Cardiac

sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk. Circulation 1998;98:961-8

135. Hautvast RWM, DeJongste MJL. Staal MJ, van Gilst WH. Lie KI. Spinal cord stimulation in chronic intractable angina pectoris: A randomized, controlled efficacy study. Am Heart J 1998; 136:1114-20

136. Olausson K, Magnusdottir H, Lurje L, Wennerblom B. Emanuelsson H. Rickstcn SE. Anti-ischemic and anti-anginal effects of thoracic epidural anesthesia versus those of conventional medical therapy in the treatment of severe refractory unstable angina pectoris. Circulation 1997:96:2178-82

137. Kwong KF, Kanellopoulos GK, Nickols JC, Pogwizd SM. Saffitz JE, Schuessler RB. Sundt TM3. Transmyocardial laser treatment dencrvates canine myocardium../ Thorac Cardiovasc Surg 1997;114:883-9

138. Minisi AJ, Thames M. Distribution of left-ventricular sympathetic afferents demonstrated by reflex responses to transmural myocardial ischemia and to intracoronary and epicardial bradykinin. Circulation 1993;87:240-6

139. Minisi AJ, Topaz O, Quinn MS, Mohanty LB. Cardiac nociceptive reflexes after transmyocardial laser revascularization: Implications for the neural hypothesis of angina relief. J Thorac Cardiovasc Surg 2001:122:712-9

140. Hirsch GM. Thompson GW, Arora RC. Hirsch K.1, Sullivan JA, Armour JA. Transmyocardial laser revascularization does not denervatc the canine heart. Ann Thorac Surg 1999:68:460-8

141. Arora RC, Hirsch GM. Hirsch KJ. Armour A. Transmyocardial laser revascularization remodels the intrinsic cardiac nervous system in a chronic setting. Circulation 2001; 104:1115-20

140

142. Kwong KF, Schuessler RB, Kanellopoulos GK, Safïitz JE, Sundt TM. Nontransmural laser treatment incompletely dcnervates canine myocardium. Circulation 1998;98:1167-71

143. Le E, Powers ER, Leong-Poi H, Rim SJ. Pelberg RA, Kaul S. Transmyocardial revascularization ameliorates ischemia by cardiac denervation and not by angiogenesis: New insights using contrast echocardiography. Circulation 2000; 102:3188

144. Hughes GG, Baklanov DV, Annex BH, Biswas SS, Kypson AP, Pippen AM, Yin BL, et al.. Denervation is not the long-term mechanism of action of transmyocardial laser revascularization. Circulation 1999; 100(Suppl I):I-249

145. Minisi AJ, Topaz O. Transmyocardial laser revascularization (TMLR) and reflexes mediated by left ventricular (LV) receptors with sympathetic afferent (SA) fibers. Circulation 2000; 102:504

146. Al-Sheikh T, Allen KB, Straka SP, Heimansohn DA, Fain RL, Hutchins GD, Sawada SG, etal.. Cardiac sympathetic denervation after transmyocardial laser revascularization. Circulation 1999;100:135-40

147. Horvath KA, Aranki SF, Cohn LH, March RJ, Frazier OH, Kadipasaoglu KA, Boyce SW, et al.. Sustained angina relief 5 years after transmyocardial laser revascularization with a CCK laser. Circulation 2001; 104:181 -184

148. Horvath KA, Greene R, Belkind N, Kane B, McPherson DD, Fullerton DA. Left ventricular functional improvement after transmyocardial laser revascularization. Ann Thorac Surg 1998;66:721-5

149. Klein M, Schulte HD, Gams E, eds. Transmyocardial laser revascularisation; Management of coronary artery diseases. Berlin: Springer, 1998

150. Okada M, ed. Current topics in transmyocardial laser revascularization. Tokyo: Medical Tribune Inc. 2001

151. Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, Angell WW, et al.. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. New Engl J Med 1999;341:1029-36

152. Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, Weiss, et al.. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: A prospective randomised trial. Lancet 1999;354:885-90

153. Frazier OH, March RJ, Horvath KA. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. New EnglJMed 1999;341:1021-8

154. Schofield PM, Sharpies LD, Caine N, Burns S, Tait S, Wistow T, Wallwork J. Transmyocardial laser revascularisation in patients with refractory angina: A randomised controlled trial. Lancet 1999;353:519-24

155. Aaberge L, Nordstrand K, Dragsund M, Saatvedt K, Endresen K, Golf S, Geiran O, et al.. Transmyocardial revascularization with C02 laser in patients with refractory angina pectoris - clinical results from the Norwegian randomized trial. J Am Coll Cardiol 2000;35:1170-7

156. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, et al.. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994;90:735-45

157. Lee JA. The pathology of cardiac ischaemia: Cellular and molecular aspects. J Pathol 1995;175:167-74 158. Dunn FG, Pringle SD. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension.

Am J Cardiol 1987;60:191-221 159. Snoeckx LH, van der Vusse GJ, Coumans WA, Willemsen PH, Reneman RS. Differences in ischaemia

tolerance between hypertrophicd hearts of adult and aged spontaneously hypertensive rats. Cardiovasc Res 1993;27:874-81

160. Herrmann HJ, Fiedler U, Blodner R. Pathogenesis of myocardial fibrosis in spontaneously hypertensive rats (SHR). Eur Heart J 1995; 16:243-52

161. Muikeshoven M, van den Brink A, Beek JF. Alternative surgical exposure of the rat heart in vivo using a simple abdominal approach. Eur Surg Res 2000;32:368-73

162. Varia MA, Calkins-Adams DP, Rinkcr LH, Kennedy AS, Novotny DB, Fowler WC, Raleigh JA. Pimonidazole: A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol Oncol 1998;71:270-7

163. Arteel GE, Raleigh J A, Bradford BU, Thurman RG. Acute alcohol produces hypoxia directly in rat liver tissue in vivo: Role of Kupffcr cells. Am J Physiol 1996:27 LG494-G500

141

References . 164. van Leeuwen TG, van Erven L, Meertens JH. Motamedi M, Post MJ, Borst C. Origin of arterial wall

dissections induced by pulsed excimcr and mid-infrared laser ablation in the pig. J Am Coll Cardiol 1992;19:1610-8

165. Bolukoglu H. Liedtke AJ. Nellis SH. Eggleston AM. Subramanian R, Renstrom B. An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am .1 Physiol 1992;263:H20-H29

166. St Louis JD, Hughes C, Kypson AP, DeGrado TR. Coleman E. Yin BL. Steenbergen C. et al.. An experimental model of chronic myocardial hibernation. Ann Thorac Surg 2000;69:1351-7

167. Mirhoseini M. Shelgikar S. Cayton MM. New concepts in revascularization of the myocardium. Ann Thorac Surg 1988;45:415-20

168. Hughes GC, Abdel-aleem S. Biswas SS. Landolfo KP. Lowe JE. Transmyocardial laser revascularization: Experimental and clinical results. Can J Cardiol 1999;15:797-806

169. Ashruf JF, Coremans JMCC. Bruining HA. Ince C. Increase of cardiac work is associated with decrease of mitochondrial NADH. Am J Physiol 1995:269:H856-62

170. van der Laan L. Coremans A, Ince C, Bruining HA. NADH videofluorimetry to monitor the energy state of skeletal muscle in vivo. J Surg Res 1998;74:155-60

171. Duchatellc JP. Vivet P. Cortes M, Groussard O. Pocidalo J J. Respiratory and haemodynamic effects of lateral thoracotomy or sternotomy in mechanically ventilated rats. Eur Surg Res 1985; 17:10-6

172. I lorstick G. Berg G\ Heimann A, Darius H, Lchr HA. Bhakdi S. Kempski O. et al.. Surgical procedure affects physiologic parameters in rat myocardial ischemia: Need for mechanical ventilation. Am J Physiol 1999;276:H472-9

173. Suma H. Optimal use of the gastro-epiploic artery. Semin Thorac Cardiovasc Surg 1996;8:24-8 174. McGinlcy JN, Knott KK. Thompson HJ. Semi-automated method of quantifying vasculamre of 1-

methyl-1-nilrosourea-induced rat mammary carcinomas using immunohistochemical detection. J Ilistochem Cylochem 2002;50:213-22

175. Belien JAM, Somi S. de Jong JS, van Diest PJ. Baak JPA. Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer. J Clin Pathol 1999;52:184-92

176. Vermeulen PB. Gasparini G, Fox SB, Colpaert C, Marson LP. Gion M, Belièn JAM, et al.. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours. Eur J Cancer 2002;38:1564-79

177. Hossler FE, Douglas JE, Douglas LE. Anatomy and morphometry of myocardial capillaries studied with vascular corrosion casting and scanning electron microscopy: A method for rat heart. Scan Electron Microsc 1986;Pt 4:1469-75

178. Minnich B, Bartcl H, Leeb H. Bemroider EWN. Krautgartner WD, Lametschwanddtner A. Quantification of microvasculature by SEM and 3D morphometry. Microsc Anal 2001;48:13-5

179. Stone GW. Tcirstein PS. Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, Mishkel G, et al.. A prospective, multicentcr, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. J Am Coll Cardiol 2002;39:1581-7

180. Lee LY, O'Hara MF, Finnin EB, Hachamovitch R. Szulc M, Kligfield PD, Okin PM, et al.. Transmyocardial laser revascularization with excimer laser: Clinical results at 1 year. Ann Thorac Surg 2000;70:498-503

181. Kavanagh GJ, Whittaker P. Prejean CA. Firth BR. Kloner RA. Kay GL. Dissociation between improvement in angina pectoris and myocardial perfusion after transmyocardial revascularization with an excimer laser. Am J Cardiol 2001 ;87:229-31

182. Burns SM, Sharpies LD. Tait S, Caine N, Wallwork J. Schofield PM. The transmyocardial laser revascularization international registry report. Eur Heart J 1999:20:31-7

183. Vincent JG, Bardos P. Kruse J. Maass D. End stage coronary disease treated with the transmyocardial C0 2 laser revascularisation: A chance for the 'inoperable' patient. Eur J Cardiothorac Surg 1997;11:888-94

184. Horvath KA, Cohn LH, Cooley DA, Crew JR, Frazier OH, Griffith BP, Kadipasaoglu K, et al.. Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg 1997;113:645-53

142

185. Nagele H, Stubbe HM. Nienaber C, Rodiger W. Results oftransmyocardial laser revascularization in non-revascularizablc coronary artery disease after 3 years follow-up. Eur Heart J 1998; 19:1525-30

186. Agarwal R, Ajit M, Kurian VM, Rajan S, Arumugam SB, Cherian KM. Transmyocardial laser revascularization: Early results and 1-year follow-up. Ann Thorac Surg 1999;67:432-6

187. Donovan CL, Landolfo KP. Hughes C. Coleman RB, Lowe JE. Intermediate clinical outcome following transmyocardial laser revascularization for end-stage coronary artery disease. Circulation 1998;98:2850

188. Hughes GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative morbidity and mortality alter transmyocardial laser revascularization: Incidence and risk factors for adverse events. J Am Coll Cardiol 1999;33:1021-6

189. Lutter G, Sarai K, Nitzsche E, Saurbier B, Frey M, Hoegerle S, Zipfel M, et al.. Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function. Thorac Cardiov Surg 2000;48:79-85

190. Krabatsch T, Petzina R, Hausmann H, Koster A, Hetzer R. Factors influencing results and outcome after transmyocardial laser revascularization. Ann Thorac Surg 2002;73:1888-92

191. March RJ, Guynn T. Cardiac allograft vasculopathy: The potential role for transmyocardial laser revascularization. J Heart Lung Transpl 1995;14:S242-S246

192. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir M, Barasch E, Conger JL, et al.. Myocardial revascularization with laser. Preliminary findings. Circulation 1995;92:1158-1165

193. Cooley DA, Frazier OH, Kadipasaoglu KA. Lindenmeir MH, Pehlivanoglu S, Kolff JW, Wilansky S, et al.. Transmyocardial laser revascularization: Clinical experience with twelve-month follow-up. J Thorac Cardiovasc Surg 1996; 111:791-7

194. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: Operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 1996:111:1047-53

195. Donovan CL, Landolfo KP. Lowe JE, Clements F, Coleman RB, Ryan T. Improvement in inducible ischemia during dobutamine stress echocardiography after transmyocardial laser revascularization in patients with refractory angina pectoris. J Am Coll Cardiol 1997;30:607-12

196. Gassier N, Stubbe HM. Clinical data and histological features oftransmyocardial revascularization with C02-Iaser. Eur J Cardiothorac Surg 1997;12:25-30

197. Hattler BG, Griffith BP, Zenati MA. Crew JR. Mirhoscini M, Cohn LH, Aranki SF, et al.. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg 1999;68:1203-9

198. Hughes GC, Landolfo KP, Lowe JE, Coleman RB. Donovan CL. Diagnosis, incidence, and clinical significance of early postoperative ischemia after transmyocardial laser revascularization. Am Heart J 1999;137:1163-8

199. Dowling RD, Petracek MR, Sellinger SL, Allen KB. Transmyocardial revascularization with a holmium laser in patients with refractory angina who are unstable. Circulation 1997;96:1358

200. Milano A, Pratali S, Tartarini G, Mariotti R, Decarlo M, Paterni G, Boni G, et al.. Early results of transmyocardial revascularization with a holmium laser. Ann Thorac Surg 1998;65:700-4

201. De Carlo M, Milano AD, Pratali S, Levantino M. Mariotti R, Bortolotti U. Symptomatic improvement after transmyocardial laser revascularization: How long does it last? Ann Thorac Surg 2000:70:1130-3

202. Sundt TM, Mohr FW, Seitclberger R, Smith CR, Robbins RC, Kvernebo K, Burkhoff D. Transmyocardial revascularization with a Ho:YAG laser: Results of 3- and 6-month follow-up. Circulation 1997;96:3155

203. Sundt TM, Kwong KF. Clinical experience with the holmium:YAG laser for transmyocardial laser revascularization and myocardial denervation as a mechanism. Seminars in Thoracic & Cardiovascular Surgery 1999:11:19-23

204. Dicgclcr A. Schneider J, Lauer B, Mohr FW, Kluge R. Transmyocardial laser revascularization using the Holium-YAG laser for treatment of end stage coronary artery disease. Eur J Cardiothorac Surg 1998;13:392-7

205. Schneider J, Diegeler A, Krakor R, Walther T, Kluge R, Mohr FW. Transmyocardial laser revascularization with the holmium: YAG laser: Loss of symptomatic improvement after 2 years. Eur J Cardiothorac Surg 2001; 19:164-9

143

References 206. Krabatsch T, Dörschel K, Tiilsner J. Transmyocardial laser revascularisation - initial results in treating

diffuse coronary disease. Lasermedizin 1995:11:192-8 207. Morgan IS. Campanclla C. Clinical feature article; Transmyocardial laser revascularisation in

Edinburgh. Brit J TheatNurs 1998;7:4-9 208. March RJ. Transmyocardial laser revascularization with the C 0 2 laser: One year results of a

randomized, controlled trial. Semin Thome Cardiovasc Surg 1999:11:12-8

209. Spertus JA, Jones PG, Coen M, Garg M, Bliven B. O'Keefe J. March RJ, et al.. Transmyocardial CO ;

laser revascularization improves symptoms, function, and quality of life: 12-Month results from a randomized controlled trial. Am J >Med2001:111:341-8

210. Weintraub WS. Jones EL, Craver JM. Grosswald R, Guyton RA. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation 1995:92 (Suppl II):50-7

211. Krabatsch T, Schaper F, Leder C, Tulsner J, Thalmann U, Hetzer R. Histological findings after transmyocardial laser revascularization. J Cardiac Surg 1996:11:326-31

212. Mirhoseini M, Shelgikar S, Cayton MM. Clinical and histological evaluation of laser myocardial revascularization. J Clin Laser Med Sur 1990:73-8

213. Cooley DA, Frazier OH. Kadipasaoglu KA. Pehlivanoglu S. Shannon RL. Angelini P. Transmyocardial laser revascularization. Anatomic evidence of long-term channel patency. Tex Heart I J 1994;21:220-4

214. Dedic K, Klima T, Cooley DA, Frazier OH, Kadipasaoglu KA, Cihan IIB. Transmyocardial laser revascularization - histopathologic^ findings. Cardiovasc Path 1998;7:63-7

215. Lulter G, Schwarzkopf J, Lutz C, Martin J, Beyersdorf F. Histologic findings of transmyocardial laser channels after two hours. Ann Thorac Surg 1998:65:1437-9

216. Huikeshovcn M, Beck .IF. van der Sloot JAP. Tukkic R, van der Meuten J. van Gemerl MJC. 35 Years of experimental research in transmyocardial laser revascularization: What have we learned? Ann Thorac Surg 2002;74:956-70

217. Spertus JA, Winder AJ, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Co/I Cardiol 1995;25:333-41

218. Buxton M, Rabin R. Pekurincn M. Bonsel G, Bjork S. Kind P. Nord E. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990:16:199-208

2 19. DePucy EG. Updated imaging guidelines for nuclear cardiology procedures, part 1 .JNucl Cardiol 2001;8:G1-G58

220. Germano G, Kavanagh PB. Wacchtcr P, Arceda J, Van Kriekinge S, Sharir T, Lewin HC, et al.. A new algorithm lor the quantitation of myocardial perfusion SPECT. 1: Technical principles and reproducibility. J Nuel Med 2000;41:712-9

221. Jaques S. Tobes MC, Sisson JC, Baker JA, Wieland DM. Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrcnomedullary cells. Mol Pharmacol 1984;26:539-46

222. Johnson LL, Thambar S, Donahay T, Dae M, Williams DO. Effect of endomyocardial laser channels on regional innervation shown with 125-I-MIBG and autoradiography. J Nuel Med 2002:43:551-5

223. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990;82:1095-105

224. Higgins TL. Estafanous FG, Loop FD, Beck GJ. Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by pre operative risk factors in coronary artery bypass patients: A clinical severity score. J Am Med Assoc 1992;267:2344-8

225. Bax JJ, Wijns W, Cornel JH, Visser FC. Bocrsma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60

226. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). 1: Conceptual framework and item selection. Med Care 1992:30:473-83

144